Alector Inc
Change company Symbol lookup
Select an option...
ALEC Alector Inc
BABA Alibaba Group Holding Ltd
JEQ abrdn Japan Equity Fund, Inc.
BAC Bank of America Corp
RVLWF Revitalist Lifestyle and Wellness Ltd
$NQUS45101010LMEURN Nasdaq US Brewers Large Mid Cap Net
$R25IG Russell 2500 Growth Index
TTC Toro Co
MPVDF Mountain Province Diamonds Inc
XFAPX abrdn Asia-Pacific Income Fund Inc
Go

Health Care : Biotechnology | Small Cap Value

Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a therapeutic approach for the treatment of neurodegeneration. The Company is engaged in developing therapies designed to counteract these pathologies by restoring healthy immune function to the brain. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration and immunology to identify immune system. The Company has advanced four product candidates, AL001, AL002, AL003, and AL101, into clinical development. Its first product candidate, AL001, is a humanized recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of frontotemporal dementia carrying a progranulin (FTD-GRN) patients. Its AL002 targets triggering receptor expressed on myeloid cells 2 (TREM2) to increase the functionality of TREM2 signaling and enhance microglia cell activation.

Closing Price: $9.49

Day's Change: -0.07 (-0.73%)

Bid: --

Ask: --

B/A Size: --

Day's High: 9.74

Day's Low: 9.28

Volume (Average) Volume: 628,550 10-day average volume: 597,509: 628,550

Nikola Corp. Stock Rises Tuesday, Outperforms Market

5:22 pm ET November 29, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Nikola Corp. (NKLA) advanced 1.73% to $2.35 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.01% to 33,852.53 and the NASDAQ Composite Index falling 0.59% to 10,983.78. Nikola Corp. closed $9.79 below its 52-week high ($12.14), which the company achieved on December 27th.

Trading volume (4.8 M) remained 8.1 million below its 50-day average volume of 12.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled November 29, 2022.

(END) Dow Jones Newswires

November 29, 2022 17:22 ET (22:22 GMT)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and